Related Experiment Video
Updated: Apr 26, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer
Xu-Ri Li1, Hui-Jun Chu2, Teng Lv2
1Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China; Department of Gynecology and Obstetrics, The Affiliated Hiser Medical Group of Qingdao University Medical College, Qingdao, China.
Abstract:
FOXM1 is a well-established oncogenic factor that has been reported to be involved in multiple biological processes including cell proliferation, growth, angiogenesis, migration and invasion. It can also be regulated by miRNAs. In this study, we reported that FOXM1 is directly targeted by miR-342-3p, which is down-regulated along with its host gene, EVL, in human cervical cancer tissues compared to the adjacent normal tissues. Functional studies suggested that the overexpression of miR-342-3p inhibits cell proliferation, migration and invasion in cervical cell lines. FOXM1 is upregulated and negatively correlates with miR-342-3p in cervical cancer tissues, and the overexpression of FOXM1 rescues the phenotype changes induced by the overexpression of miR-342-3p.
Insights
MicroRNA-342-3p (miR-342-3p) targets the oncogenic factor Forkhead box M1 (FOXM1) in cervical cancer. Restoring miR-342-3p inhibits cancer cell growth, while FOXM1 promotes it.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Forkhead box M1 (FOXM1) is a known oncogenic transcription factor implicated in cell proliferation, angiogenesis, migration, and invasion.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and can act as tumor suppressors or oncogenes.
- Dysregulation of FOXM1 and miRNAs is frequently observed in various cancers, including cervical cancer.
Purpose of the Study:
- To investigate the regulatory relationship between miR-342-3p and FOXM1 in human cervical cancer.
- To elucidate the functional role of miR-342-3p in cervical cancer progression.
- To determine the impact of FOXM1 on the biological behavior of cervical cancer cells.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess miR-342-3p and FOXM1 expression levels in cervical cancer tissues and cell lines.
- Bioinformatic analysis and luciferase reporter assays to confirm direct targeting of FOXM1 by miR-342-3p.
- In vitro functional assays (cell proliferation, migration, invasion assays) to evaluate the effects of miR-342-3p and FOXM1 overexpression.
- Western blotting to analyze protein expression levels.
Main Results:
- miR-342-3p and its host gene EVL were significantly downregulated in human cervical cancer tissues compared to adjacent normal tissues.
- FOXM1 was upregulated in cervical cancer tissues and exhibited an inverse correlation with miR-342-3p levels.
- Overexpression of miR-342-3p suppressed cervical cancer cell proliferation, migration, and invasion.
- Overexpression of FOXM1 reversed the inhibitory effects of miR-342-3p on cervical cancer cell phenotypes.
Conclusions:
- miR-342-3p directly targets and represses FOXM1 expression in cervical cancer.
- miR-342-3p functions as a tumor suppressor by inhibiting proliferation, migration, and invasion in cervical cancer.
- The miR-342-3p/FOXM1 axis represents a potential therapeutic target for cervical cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...

